FRIDAY, June 23, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved the drug Elevidys, the first gene therapy for the treatment of children with Duchenne muscular dystrophy (DMD). The groundbreaking treatment will not be cheap: Drugmaker Sarepta Therapeutics Inc. said it would charge $3.2 millionContinue Reading

THURSDAY, June 22, 2023 (American Heart Association News) — At the doctor’s office, questions about a person’s family health history often can help health care professionals determine the risk of developing chronic conditions, including heart disease, high blood pressure and diabetes. But among many Latino people, especially immigrants, talking aboutContinue Reading